Sales decline 72.74% to Rs 2.53 crore
Net Loss of Parmax Pharma reported to Rs 2.08 crore in the quarter ended September 2025 as against net loss of Rs 0.22 crore during the previous quarter ended September 2024. Sales declined 72.74% to Rs 2.53 crore in the quarter ended September 2025 as against Rs 9.28 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var.Sales2.539.28 -73 OPM %-62.852.05 -PBDT-1.820.18 PL PBT-2.08-0.22 -845 NP-2.08-0.22 -845Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
